Albireo Pharma, Inc. Made Headway

Mon, Jan 09, 2023 at 07:02 PM
Albireo Pharma, Inc. Made Headway

Albireo Pharma, Inc. (ALBO:NASDAQ) jumped higher at $43.85, representing a gain of 92.2%. On Mon, Jan 09, 2023, ALBO:NASDAQ hit a New 2-Week High of $43.85. The stock got featured on our News Catalysts scanner on Mon, Jan 09, 2023 at 02:14 PM in the 'ACQUISITION' category. From Tue, Dec 27, 2022, the stock recorded 62.50% Up Days and 55.56% Green Days

About Albireo Pharma, Inc. (ALBO:NASDAQ)

Albireo Pharma Inc is a development-stage pharmaceutical company. It engages in the research and development of the drug reformulation technology. The company is engaged in the development an oral insulin to treat diabetes.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.